益生菌应用于结直肠癌三级预防中的研究进展  

Research progress of probiotics in the tertiary prevention of colorectal cancer

作　　者：程海霞 贾增增 徐月姣 范国权[2] 何若冲[3] Cheng Haixia;Jia Zengzeng;Xu Yuejiao;Fan Guoquan;He Ruochong(Department of General Surgery, Shanxi Dayi Hospital Affliated to Shanxi Medical Vniversity, Taiyuan 030001, China （ Cheng HX, Jia ZZ, Xu Y J;Department of Immune, Shanxi Medical University, Taiyuan 030001, China （ Fan GQ;Department of General Surgery, Shanxi Academy of Medical Sciences, Shanxi Grand Hospital, Taiynan 030032, China （He RC)

机构地区：[1]山西医科大学附属大医院普通外科,太原030001 [2]山西医科大学免疫教研室,太原030001 [3]山西医学科学院山西大医院普通外科,太原030032

出　　处：《中华实验外科杂志》2018年第7期1373-1375,共3页Chinese Journal of Experimental Surgery

摘　　要：近年来结直肠癌的发病率逐年上升，其三级预防成为研究的热点。益生菌是一类有益于肠道微生态平衡的优势菌群，目前益生菌也逐步应用于结直肠癌的三级预防中，本文就益生菌在结直肠癌三级预防中的研究进行简要回顾及展望。In recent years, the incidence af eoloreetal cancer has been gradually increased, the tertiary prevention of colorectal cancer is becoming an advanced research hotspot, probiotics are a group of dominant bacteria that benefit the intestinal microeeologieal balance. Currently probiotics are also gradually used in the tertiary prevention of colorectal cancer. In this paper, we reviewed and prospected the research of probiotics in the tertiary prevention of eolorectal cancer.

关 键 词：结直肠癌 三级预防 益生菌 

分 类 号：R735.34[医药卫生—肿瘤]